Search Results 2601-2610 of 12924 for immunosuppressant drugs

  1. Mayo Clinic and Collaborators Find New Class of Drugs that Reduces Aging in Mice

    A new class of drugs identified and validated by Mayo Clinic researchers along with collaborators at Scripps Research Institute and others, clearly reduces ...

  2. Mayo Clinic joins coalition to end drug shortages

    Mayo Clinic has joined the End Drugs Shortages Alliance, a coalition that seeks to prevent drug shortages in the U.S..

  3. Study finds drug therapy can delay onset of myeloma symptoms - Mayo Clinic News Network

    CHICAGO — The largest randomized trial involving smoldering multiple myeloma suggests that lenalidomide, a cancer drug, may delay the onset of myeloma ...

  4. Testing The Addition Of An Anti-Cancer Drug, Gemcitabine, To Usual Treatment (BCG Alone) In People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy - Mayo Clinic

    Testing The Addition Of An Anti-Cancer Drug, Gemcitabine, To Usual Treatment (BCG Alone) In People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back ...

  5. Tumors And Masses Clinical Trials - Mayo Clinic Research

    Drugs used in chemotherapy, such as AFP464, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from ...

  6. Understanding Drug-resistant Superbugs - Mayo Clinic News Network

    The term superbug isn't very specific. It refers to a broader issue we are having in medicine of bacteria becoming resistant to routine antibiotics, making them ...

  7. Five Ways Individualized Medicine is Impacting Health Care

    That's just what Mayo Clinic Vice President Gianrico Farrugia, M.D., did this morning in his opening keynote at the 4th annual Individualizing Medicine ...

  8. COVID-19: Who's at higher risk of serious symptoms? - Mayo Clinic

    Use of medicines that lower the immune system's ability to respond to germs. Also, as a general group, disability is linked to an increased risk of severe COVID ...

  9. Oncology (Medical) - Clinical trials - Mayo Clinic

    Venetoclax is FDA approved for the treatment of CLL and SLL. The drug combination of acalabrutinib, durvalumab, and venetoclax is experimental and isn't ...

  10. Clinical trials - Oncology (Medical)

    Venetoclax is FDA approved for the treatment of CLL and SLL. The drug combination of acalabrutinib, durvalumab, and venetoclax is experimental and isn't ...